WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

	Investing in Government Affairs to Access Your Market Potential in China: Key Co...
	Government affairs expert Jonathan Zhu observes a common organization "flaw" in life science companies to underestimate the importance of the government affairs... (2/2/2012)

Biospectrum: Asia bullish on biologics manufacturing (2/6/2012)

Innovating in China's Pharma Market: McKinsey's Interview with Steve Yang, AstraZeneca's Head of R&D in Asia and Emerging Markets (External) (2/3/2012)

Investing in Government Affairs to Access Your Market Potential in China: Key Considerations (2/2/2012)

Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2011 (1/26/2012)

Contemporary Challenges May Dim Prospects in the Year of the Water Dragon (1/23/2012)

IMS Health: China Pharmaceutical Market Snapshot in Q3/2011 (1/23/2012)

China Learns the Lesson of Vaccine R&D Bubble - The Story of Chongqing Brewery's in Development of Its Novel HepB Vaccine (1/17/2012)

OneMedPlace China Forum - Pharma Faces China Healthcare Challenge (1/11/2012)

When Old Dogs Meet New Tricks - 2011 Academic Marketing Recognition Ranking for International Pharmaceutical Companies in China (1/11/2012)

Research Partnership between BMS and Simcere: The Right Chemistry Amid A Global Paradim Shift of Drug R&D (1/9/2012)

Pharmaceutical Executive: Hard Times Before the Harvest for Pharma in 2012 (1/9/2012)

Long Term Outlook Remains Positive for MNCs Despite Pricing Pressures and Uncertainties (12/31/2011)

Chinese Pharma Espionage? (12/15/2011)

Chinese Physicians Are More Digitally Savvy Than You Think (12/8/2011)

Review of Chinese Pharma Industry Performance in the First Three Quarters (12/7/2011)


	China emerging as an innovation hub for formulation and delivery (2/7/2012)
	Takeda in acquisition talkes with three mid-size Indian firms (2/7/2012)
	Shanghai Pharma acquires another major API producer (2/7/2012)
	Latest executive moves (2/7/2012)
	Upcoming Event: BioChina International 2012 (2/6/2012) (free)
	Allergan taps China as its future growth driver (2/3/2012)
	Cardinal Health sets aside US$90M for acquisitions in China (2/3/2012)
	Nanjing Pharma reports loss for 2011, making it an ideal target for acquisition (2/3/2012)
	Bloomburg: Wuxi PharmaTech and ShangPharma ripe for takeover by global rivals (2/3/2012)
	Big pharma companies join hands to fight neglected tropical diseases (2/3/2012)
	AstraZeneca has announced plans to cut 7,300 jobs (2/3/2012)
	Beijing's CNY 30B drug market under threat of the "Anhui Model" (2/3/2012)

	Takeda in acquisition talkes with three mid-size Indian ...
	Big pharma companies join hands to fight neglected tropi...
	AstraZeneca has announced plans to cut 7,300 jobs
	Global pharma deal-making fell 18% in 2011
	New study: drug companies expand use of strategic partne...

	Data snapshot: hospital oncology drug consumption of six cities...
	Chinese pharma growth expected to slow mildly in 2012
	Barclays Capital: Downside to prevail in 2012 for China healthc...
	Chinese Pharma import and export jumped 40% in the first ten mo...
	Chinese online retail drug sales estimated to be around CNY 400...

	China emerging as an innovation hub for formulation and deli...
	Allergan taps China as its future growth driver
	Cardinal Health sets aside US$90M for acquisitions in China
	Nanjing Pharma reports loss for 2011, making it an ideal tar...
	Bloomburg: Wuxi PharmaTech and ShangPharma ripe for takeover...

	CDE initiates regulation of clinical data management at ...
	Major drug regulations and laws currently under drafting...
	SFDA to launch a nationwide correction campaign as it la...
	SFDA issues notice to strengthen regulation of API mixed...
	China suspends approval and clinical trial of stem cell ...

	SFDA terminates administrative protection of two Roche produ...
	Chinese expert calls for revision of the Drug Administration...
	Drug salesman and physicians sentenced to prison for corrupt...
	Former Sanofi researcher face prison sentence for technology...
	USTR Issues Report on China's Compliance with WTO and TRIPS

	Shanghai Pharma acquires another major API producer
	Dishman close to a deal selling its brand new Chinese AP...
	India to inspect six Chinese API manufacturing facilitie...
	Shanghai Pharma acquires oncology API maker
	Chinese pharma companies targeted by environmental agenc...

	China approves the world's first hepetitis E vaccine
	Sinovac initiates phase III clinical research for its EV...
	Simcyp launches virtual Chinese patient population tool
	GSK China R&D partners with ProteoTech for new Parki...
	Two new pharmaceutical research institutions established...

	Beijing's CNY 30B drug market under threat of the "Anhui...
	MOH issues its key health tasks in 2012
	Health Minister Chen Zhu reviews healthcare reform achie...
	MOH bans officials from any involvements with drug procu...
	MOH issues guidelines for clinical cancer pain managemen...

	Latest executive moves
	Senior BMI official in Nanjing handed prison sentence for ...
	Recent executive moves
	Recent executive moves
	Recent official and executive moves

	Upcoming Event: BioChina International 2012
	Upcoming event: Pharma China Seminar 2011 in NJ on April...
	Upcoming event: Pharma China Annual Forum 2012 on March ...
	China's urban population exceeds rural residents for the...
	Upcoming Event: 4th Vaccines China 2012

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

WiCON officially publishes Chi...

WiCON publishes China Pharmace...

Pharma China adds one more dis...

WiCON Launches China Pharmaceu...

Pharma China adds another dist...

Site map | Contact Us | Links